<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-29-2020-03602-998-43082</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="SV">A new and better test for tuberculosis</narrative>
   <narrative xml:lang="EN">En ny och b&#xE4;ttre test f&#xF6;r tuberkulos</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="SV">En fj&#xE4;rdedel av v&#xE4;rldens befolkning ber&#xE4;knas vara latent infekterade med tuberkelbakterier och mer &#xE4;n 10 miljoner m&#xE4;nniskor insjuknar varje &#xE5;r i aktiv tuberkulos (tbc).&#xA0;Det saknas fortfarande ett enkelt, snabbt och patientn&#xE4;ra test f&#xF6;r att diagnosticera aktiv TB. Detta &#xE4;r s&#xE4;rskilt viktigt f&#xF6;r barn och personer med nedsatt immunf&#xF6;rsvar d&#xE4;r nuvarande metoder &#xE4;r mycket bristf&#xE4;lliga. Det saknas ocks&#xE5; en test f&#xF6;r att f&#xF6;ruts&#xE4;ga vilka som &#xE4;r latent infekterade kommer att utveckla aktiv sjukdom.&#xA0;M&#xE5;l:Vi avser i) att vidareutveckla och utv&#xE4;rdera nya av oss utvecklade diagnostiska test f&#xF6;r aktiv TB i patientgrupper i bland annat Sverige, Sydafrika och Mozambique&#xA0; samt ii) forska fram ett diagnostiskt test f&#xF6;r att identifiera latent infekterade med risk att utveckla aktiv sjukdom.&#xA0;Betydelse:&#xA0;En person med aktiv TB ber&#xE4;knas att under ett &#xE5;r smitta 10-15 individer. Att snabbt hitta nya patienter och de med risk att utveckla sjukdom och behandla dem &#xE4;r d&#xE4;rf&#xF6;r det viktigaste s&#xE4;ttet att hindra fortsatt smittspridning och att p&#xE5; sikt bek&#xE4;mpa tuberkulosepidemin.</narrative>
   <narrative xml:lang="EN">The purpose of this project is todetermine how mycobacterial glycolipid lipoarabinomannan (LAM) and&#xA0;its precursor phosphatidyl-myo-inositol mannoside (PIM)can be used for the identification and follow up of patients with active and latent tuberculosis (TB). Tests to rapidly provide information useful for the clinical management in different clinical settings will be developed and evaluated.Our aims are:To determine the performance of a new prototype of our urinary LAM test for: i) the diagnosis of active TB; and ii) to identify patients with LTB at high risk of developing active TB.To define new diagnostic biomarkers based on LAM and PIM to detect patients with latent TB and identify those who will progress to active TB.Achieving these aims will improve rapid diagnosis, early treatment initiation and reduce transmission which will reduce patient suffering and is absolutely needed to fulfill the WHO and Agenda 2030 goals of eliminating TB.</narrative>
  </description>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">Karolinska Institutet</narrative>
  </participating-org>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-01-01" type="1"></activity-date>
  <activity-date iso-date="2021-01-01" type="3"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-region code="998" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Developing countries, unspecified</narrative>
  </recipient-region>
  <sector code="430" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Other Multisector</narrative>
  </sector>
  <sector code="43082" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Research/scientific institutions</narrative>
  </sector>
  <tag code="9.5" vocabulary="3">
   <narrative xml:lang="EN">9.5 - Enhance scientific research, upgrade the technological capabilities of industrial sectors in all countries, in particular developing countries, including, by 2030, encouraging innovation and substantially increasing the number of research and development workers per 1&#xA0;million people and public and private research and development spending.</narrative>
   <narrative xml:lang="SV">9.5 - F&#xF6;rb&#xE4;ttra forskningen och industrisektorernas tekniska kapacitet i alla l&#xE4;nder, i synnerhet utvecklingsl&#xE4;nderna, bland annat genom att till 2030 uppmuntra innovation och v&#xE4;sentligt &#xF6;ka det antal personer som arbetar med forskning och utveckling per 1 miljon m&#xE4;nniskor liksom de offentliga och privata utgifterna f&#xF6;r forskning och utveckling.</narrative>
  </tag>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="1" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-28"></period-end>
   <value currency="USD" value-date="2021-01-01">181547.7159950921</value>
  </budget>
  <budget>
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-28"></period-end>
   <value currency="USD" value-date="2022-01-01">181547.7159950921</value>
  </budget>
  <budget>
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-12-28"></period-end>
   <value currency="USD" value-date="2023-01-01">116399.0140829777</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-11-24"></transaction-date>
   <value currency="USD" value-date="2020-11-24">479494.446073162</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-28"></transaction-date>
   <value currency="USD" value-date="2021-01-28">136160.4612528095</value>
  </transaction>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
